0001631734-19-000002.txt : 20190712 0001631734-19-000002.hdr.sgml : 20190712 20190712144437 ACCESSION NUMBER: 0001631734-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190712 DATE AS OF CHANGE: 20190712 EFFECTIVENESS DATE: 20190712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Breethe, Inc. CENTRAL INDEX KEY: 0001631734 IRS NUMBER: 465765625 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-342366 FILM NUMBER: 19952870 BUSINESS ADDRESS: STREET 1: 1101 W. PRATT STREET STREET 2: SUITE 3B CITY: BALTIMORE STATE: MD ZIP: 21223 BUSINESS PHONE: 410-328-3822 MAIL ADDRESS: STREET 1: 1101 W. PRATT STREET STREET 2: SUITE 3B CITY: BALTIMORE STATE: MD ZIP: 21223 D/A 1 primary_doc.xml X0708 D/A LIVE 0001631734 Breethe, Inc. 1500 Joh Avenue Suite 190 Halethorpe MD MARYLAND 21227 410-328-3822 DELAWARE None None Corporation true Carl A. Cohen c/o Breethe, Inc. 1500 Joh Avenue, Suite 190 Halethorpe MD MARYLAND 21227 Director Bartley Griffith c/o Breethe, Inc. 1500 Joh Avenue, Suite 190 Halethorpe MD MARYLAND 21227 Director Marshal Linder c/o Breethe, Inc. 1500 Joh Avenue, Suite 190 Halethorpe MD MARYLAND 21227 Executive Officer Director Chief Executive Officer Donald W. Fallon c/o Breethe, Inc. 1500 Joh Avenue, Suite 190 Halethorpe MD MARYLAND 21227 Executive Officer Chief Financial Officer, Secretary, Treasurer and Senior VP Steven Orwig c/o Breethe, Inc. 1500 Joh Avenue, Suite 190 Halethorpe MD MARYLAND 21227 Executive Officer Senior VP, Assistant Secretary and Assistant Treasurer Biotechnology Decline to Disclose 06b true 0001631734-19-000001 2019-06-07 false true false 1 Gravitas Healthcare Partners, LLC None INTE SECURITIES LLC 47107 612 Cascade Springs Drive Southlake TX TEXAS 76092 MD MARYLAND MA MASSACHUSETTS MN MINNESOTA PA PENNSYLVANIA TX TEXAS false 8000000 8000000 0 This filing covers the sale and issuance of Series 6 Preferred Stock and the underlying Common Stock issuable upon conversion thereof. false 24 120000 0 In addition to the sales commission of $120,000, Recipient received from Issuer a warrant that is exercisable into 16,000 shares of Common Stock at the exercise price equal to the Series 6 per-share price. 0 false Breethe, Inc. /s/ Marhsal Linder Marshal Linder Chief Executive Officer 2019-07-09